GFP
LLY icon

Gryphon Financial Partners’s Eli Lilly LLY Stock Holding History

Gryphon Financial Partners’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.7M Buy
6,418
+750
+13% +$766K 0.68% 26
2026
Q1 		$5.21M Buy
5,668
+465
+9% +$471K 0.53% 32
2025
Q4 		$5.59M Buy
5,203
+224
+4% +$214K 0.6% 25
2025
Q3 		$3.8M Buy
4,979
+729
+17% +$542K 0.43% 33
2025
Q2 		$3.31M Buy
4,250
+23
+0.5% +$17.9K 0.43% 33
2025
Q1 		$3.49M Buy
4,227
+409
+11% +$340K 0.5% 30
2024
Q4 		$2.95M Sell
3,818
-528
-12% -$437K 0.42% 35
2024
Q3 		$3.85M Buy
4,346
+339
+8% +$305K 0.52% 27
2024
Q2 		$3.63M Buy
4,007
+294
+8% +$235K 0.54% 26
2024
Q1 		$2.89M Buy
3,713
+1,389
+60% +$989K 0.48% 28
2023
Q4 		$1.35M Buy
2,324
+377
+19% +$220K 0.24% 63
2023
Q3 		$1.05M Sell
1,947
-33
-2% -$17K 0.24% 53
2023
Q2 		$929K Sell
1,980
-6
-0.3% -$2.52K 0.2% 62
2023
Q1 		$682K Buy
1,986
+453
+30% +$153K 0.16% 75
2022
Q4 		$561K Buy
1,533
+43
+3% +$15.2K 0.13% 91
2022
Q3 		$482K Buy
1,490
+89
+6% +$28.2K 0.12% 99
2022
Q2 		$454K Buy
1,401
+223
+19% +$66.9K 0.11% 104
2022
Q1 		$337K Buy
1,178
+94
+9% +$24.2K 0.07% 146
2021
Q4 		$300K Buy
1,084
+43
+4% +$10.9K 0.06% 167
2021
Q3 		$241K Buy
1,041
+50
+5% +$12.3K 0.05% 172
2021
Q2 		$194K Buy
+991
New +$199K 0.04% 165
2018
Q3 		– Sell
-1,168
Closed -$99K – 549
2018
Q2 		$99K Buy
1,168
+14
+1% +$1.15K 0.04% 132
2018
Q1 		$90K Sell
1,154
-120
-9% -$9.66K 0.05% 150
2017
Q4 		$107K Buy
+1,274
New +$108K 0.06% 134

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Gryphon Financial Partners's LLY Position: Q2 2026 in Review

Gryphon Financial Partners increased its Eli Lilly (LLY) stake by 13% in Q2 2026, buying an estimated $766K and bringing the position to 6,418 shares worth $7.7M. The position accounts for 0.68% of the portfolio, ranked #26.

Gryphon Financial Partners first reported a position in LLY in Q4 2017 and has held it in 24 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Gryphon Financial Partners held 6,418 shares of Eli Lilly worth $7.7M as of Q2 2026.
  • Gryphon Financial Partners bought 750 Eli Lilly shares in Q2 2026, an estimated $766K.
  • Eli Lilly made up 0.68% of Gryphon Financial Partners's portfolio in Q2 2026, its #26 holding.
  • Gryphon Financial Partners first reported a position in Eli Lilly in Q4 2017 and has held it in 24 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Gryphon Financial Partners's 13F filing for Q2 2026, filed 5 Aug 2026.